Вернуться к статье
Морфология зоны имплантации синтетических герниопротезов, модифицированных углеродом
Table 1 - Study group "Ecoflon," Subgroups with Coating and without Coating
| Groups | Observation periods | Reliability of differences | ||
Day 7 | Day 14 | 180th day | |||
Infiltrate thickness, µm | Control | 175±25 | - | - | P1*=0.04 P2*>>0.05 P3*>>0.05 |
With coating | 125±25 | - | - | ||
Polymorphonuclear leukocytes,% | Control | 52±8 | 30±5 | - | P1*<<0.01 P2*=0.01 P3*>>0.05 |
With coating | - | 12±3 | - | ||
Small lymphocyte type cells,% | Control | 22±3 | 17±3 | - | P1*<<0.01 P2*=0.08 P3*<<0.01 |
With coating | - | 12±3 | 9±1 | ||
Histiocytes,% | Control | 22±3 | 30±2 | 40±4 | P1*=0.02 P2*=0.01 P3*<<0.01 |
With coating | 37±7 | 7±1 | - | ||
Foreign body giant multinucleated cells (FBGCs) | Control | 3±2 | 10±1 | - | P1*<<0.01 P2*<<0.01 P3*<<0.01 |
With coating | - | - | - | ||
Capsule thickness, µm | Control | - | 200±30 | 90±10 | P1*>>0.05 P2*=0.04 P3*=0.02 |
With coating | - | 147±22 | 55±5 | ||
